Pain Therapeutics Balance Sheet - Annual (NASDAQ:PTIE)

Add to My Stocks
$0.96 $0.01 (1.05%) PTIE stock closing price Sep 18, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Pain Therapeutics balance sheet. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Pain Therapeutics stock analysis. Annual results are typically accompanied with the company releasing financial statements. Pain Therapeutics balance sheet indicates an asset turnover ratio of 0 and debt to equity ratio of 0. Also check Pain Therapeutics revenue and Pain Therapeutics operating cash flow for the same period.

View latest 10 year balance sheet data to check Pain Therapeutics financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Cash10.47M16.61M31.29M40.59M48.58M49.35M73.14M4.79M35.79M153.15M
Marketable Securities-2.09M--1.25M6.89M24.98M86.42M139.96M36.93M
Receivables-------7.11M--
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets--------2.71M-
Total Current Assets
10.66M19.07M31.69M40.82M50.1M56.5M98.48M98.48M178.47M190.63M
Property Plant & Equipment------1.33M1.33M1.33M1.33M
Accumulated Depreciation------1.2M1.04M--
Net Property Plant & Equipment
----------
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets--------3.01M2.02M
Total Assets
10.83M19.3M31.91M40.9M50.1M56.85M98.96M99.19M182M193.43M
Notes Payable----------
Accounts Payable--1.03M----1.1M1.31M2.21M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses--1.51M-1.35M1.8M1.91M2.06M2.84M3.55M
Income Taxes Payable----------
Other Current Liabilities-----7.83M10.89M10.89M14.34M14.34M
Total Current Liabilities
1.13M-2.55M-1.8M9.99M13.27M14.07M18.51M20.11M
Mortgages----------
Deferred Taxes/Income-----33.72M41.29M52.19M55.24M69.03M
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
1.13M-2.55M-1.8M43.72M54.57M66.26M73.75M89.15M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus167.09M164.07M159.95M156.5M152.36M148.73M176.42M161.95M225.43M218.02M
Retained Earnings-157.39M-145.48M-130.63M-116.49M-104.1M-135.65M-132.2M-129.59M-117.56M-114.1M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity9.69M18.63M29.36M40.05M48.3M13.13M44.39M32.93M108.25M104.28M
Total Liabilities & Shareholders Equity10.83M19.3M31.91M40.9M50.1M56.85M98.96M99.19M182M193.43M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Durect financial analysis

Apart from balance sheet items, an investor would do well to keep track of the Pain Therapeutics stock price by looking at Pain Therapeutics historical stock prices. One can compare PE with industry average by looking at the Pain Therapeutics PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like Pain Therapeutics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for PTIE stock as of 2017 is $10.83M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. PTIE stock had total liabilities of $1.13M for the year 2017.

Pain Therapeutics Balance Sheet - Key Ratios

Current ratio
7.52
Debt to equity ratio
0
Asset turnover ratio
0
Receivables turnover
0

Annual Balance Sheets For Pain Therapeutics, Inc. Peers

Durect balance sheet, Egalet balance sheet, KemPharma balance sheet, Tonix Pharma balance sheet